Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching

Genetic Testing

Volumn 6, Issue 2, 2002, Pages 79-87

  Hallowell, N ^a   Foster, C ^a   Ardern Jones, A ^b   Eeles, R ^a   Murday, V ^c   Watson, M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; METHODOLOGY; MIDDLE AGED; MUTATION; OVARY TUMOR; RETROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE; ALTRUISM; ANAMNESIS; ANXIETY; BREAST CANCER; CELL TYPE; CLINICAL ARTICLE; CLINICAL PRACTICE; DECISION MAKING; EMOTION; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEALTH CARE COST; ONCOGENE; OVARY CANCER; PATIENT ATTITUDE; PATIENT COUNSELING; RISK MANAGEMENT;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0036591549     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/10906570260199320     Document Type: Article

References (23)

1. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2
2. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2
3. Experiences of gentic risk: Disclosure and the gendering of responsibility
4. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: Findings from a focus group and a needs-assessment survey
5. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
6. Genetic testing for breast & ovarian cancer predisposition: Cancer burden and responsibility
7. Predictive testing for BRCA1/2: Attributes, risk perception and management in a multi-centre clinical cohort
8. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing
9. Doing the right thing: Genetic risk and responsibility
10. Surveillance or surgery? A description of the factors that influence high-risk premenopausal women's decisions about prophylactic oophorectomy
11. Cancer genetic clinics: Why do women who already have cancer attend?
12. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: An exploration of attitudes and psychological functioning during genetic testing
13. Psychological impact of receiving a BRCA1/BRCA2 test result
14. A strong candidate for the breast ovarian cancer susceptibility gene BRCA1
15. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2
16. Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective
17. Prevalence and contribution of BRCA1 mutations in breast and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
18. Knowledge of breast cancer genetics among breast cancer patients and first-degree relatives of affected individuals
19. Identification of the breast cancer susceptibility gene BRCA2